Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan

Journal of Medical Microbiology

Volumn 56, Issue 5, 2007, Pages 650-653

  Wang, Jang Shiun ^a,b   Li, Shu Ying ^c   Yang, Yun Liang ^d   Chou, Hsiao Hui ^c   Lo, Hsiu Jung ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA TROPICALIS; CLUSTER ANALYSIS; FUNGUS ISOLATION; GENETIC ASSOCIATION; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; TAIWAN;

ANTIFUNGAL AGENTS; CANDIDA TROPICALIS; CANDIDIASIS; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FLUCONAZOLE; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TAIWAN;

EID: 34248186548     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46664-0     Document Type: Article

References (17)

1. Arthington-Skaggs, B. A., Lee-Yang, W., Ciblak, M. A., Frade, J. P., Brandt, M. E., Hajjeh, R. A., Harrison, L. H., Sofair, A. N. & Warnock, D. W. (2002). Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother 46, 2477-2481.
2. Chen, Y. C., Chang, S. C., Tai, H. M., Hsueh, P. R. & Luh, K. T. (2001). Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 100, 791-797.
3. Chen, K. W., Lo, H. J., Lin, Y. H. & Li, S. Y. (2005). Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol 54, 249-258.
4. Cheng, M. F., Yu, K. W., Tang, R. B., Fan, Y. H., Yang, Y. L., Hsieh, K. S., Ho, M. & Lo, H. J. (2004). Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 48, 33-37.
5. Clinical and Laboratory Standards Institute (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, approved standard M27-A. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Ergon, M. C. & Gulay, Z. (2005). Molecular epidemiology of Candida species isolated from urine at an intensive care unit. Mycoses 48, 126-131.
7. Lee, M. K., Williams, L. E., Warnock, D. W. & Arthington-Skaggs, B. A. (2004). Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 53, 217-224.
8. Li, S. Y., Yang, Y. L., Chen, K. W., Cheng, H. H., Chiou, C. S., Wang, T. H., Lauderdale, T. L., Hung, C. C. & Lo, H. J. (2006). Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. Epidemiol Infect 134, 265-269.
9. Lo, H.-J., Ho, Y.-A. & Ho, M. (2001). Factors accounting for misidentification of Candida species. J Microbiol Immunol Infect 34, 171-177.
10. Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S. & Hollis, R. J. (2000). Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 44, 747-751.
11. Roilides, E., Farmaki, E., Evdoridou, J., Francesconi, A., Kasai, M., Filioti, J., Tsivitanidou, M., Sofianou, D., Kremenopoulos, G. & Walsh, T. J. (2003). Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 41, 735-741.
12. Sanglard, D. & Odds, F. C. (2002). Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2, 73-85.
13. Tavanti, A., Davidson, A. D., Johnson, E. M., Maiden, M. C., Shaw, D. J., Gow, N. A. & Odds, F. C. (2005). Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol 43, 5593-5600.
14. Walsh, T. J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E. & Anaissie, E. (2004). Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10 (Suppl. 1), 48-66.
15. Yang, Y. L., Cheng, H. H., Ho, Y. A., Hsiao, C. F. & Lo, H. J. (2003). Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect 36, 187-191.
16. Yang, Y. L., Ho, Y. A., Cheng, H. H., Ho, M. & Lo, H. J. (2004). Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 25, 60-64.
17. Yang, Y. L., Ho, Y. A., Cheng, H. H. & Lo, H. J. (2005). Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan. Epidemiol Infect 133, 325-330.